Le. Gamadia et al., Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers, BLOOD, 98(3), 2001, pp. 754-761
During immunosuppression, cytomegalovirus (CMV) can reactivate and cause se
rious clinical problems. Normally, abundant virus replication is suppressed
by immune effector mechanisms. To study the interaction between CD8(+) T c
ells and persisting viruses, frequencies and phenotypes of CMV-specific CD8
(+) T cells were determined in healthy individuals and compared to those in
renal transplant recipients. In healthy donors, function of circulating vi
rus-specific CD8(+) T cells, as measured by peptide-induced interferon gamm
a (IFN-gamma) production, but not the number of virus-specific T cells enum
erated by binding of specific tetrameric peptide/HLA complexes, correlated
with the number of CMV-specific IFN-gamma -secreting CD4(+) helper T cells.
Circulating CMV-specific CD8(+) T cells did not express CCR7 and may there
fore not be able to recirculate through peripheral lymph nodes. Based on co
expression of CD27 and CD45R0 most CMV-specific T cells in healthy donors a
ppeared to be memory-type cells. Remarkably, frequencies of CMV-specific CD
8(+) T cells were significantly higher in immunosuppressed individuals than
in healthy donors. In these patients CMV-specific cells predominantly had
an effector phenotype, that is, CD45R0(+)CD27(-)CCR7(-) or CD45RA(+)CD27(-)
CCR7(-) and contained both granzyme B and perforin. Our data show that In r
esponse to immunosuppressive medication quantitative and qualitative change
s occur In the CD8(+) T-cell compartment. These adaptations may be Instrume
ntal to maintain CMV latency. (C) 2001 by The American Society of Hematolog
y.